LEO Pharma
Leo Pharma reveals positive results for its JAK cream in hand eczema, competing with Incyte’s Opzelura
Anika Sharma
In February, Leo Pharma created a buzz by announcing the success of its JAK-inhibitor cream, delgocitinib, in a phase 3 ...
LEO Pharma Set to Acquire Timber Pharmaceuticals
Anika Sharma
Timber Pharmaceuticals has exciting news to share—the company is set to be acquired by LEO US Holding, Inc., a wholly-owned ...
